Nephrology
Oncology
Patients With Kidney Disease May Have An Increased Risk Of Cancer
Kidney Disease and Cancer Risk
Kidney Disease and Cancer Risk
Patients with kidney disease may have an increased risk of cancer and may be more likely to die from cancer. Researchers used healthcare databases in Ontario, Canada, to categorize patients according to their kidney function (using blood test data) or records that identify patients receiving dialysis or patients with kidney transplants. They then looked at the patients' risk of being diagnosed with cancer and of dying of cancer.
Patients with mild to moderate kidney disease and kidney transplant recipients had a higher risk of cancer than patients with normal kidney function. Patients with kidney disease had a higher risk of dying from cancer than patients with normal kidney function, particularly from cancers such as:
- Bladder cancer
- Kidney cancer
- Multiple myeloma
This study, published in the American Journal of Kidney Diseases (AJKD), suggests that improved strategies to detect and treat cancer in patients with kidney disease are needed.
To view the full article, visit here: 10.1053/j.ajkd.2022.02.020
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!